Latest research report on “In-Vitro Diagnostics Market” now available at high quality database of ReportsnReports.com with market size, share, trends, competitive and statistical analysis. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample Research Copy @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5561146
In-Vitro Diagnostics (IVD) is the test for detecting diseases. In this report, we counted In-Vitro Diagnostics reagent.
This report contains market size and forecasts of In-Vitro Diagnostics in Global, including the following market information:
Global In-Vitro Diagnostics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global In-Vitro Diagnostics market was valued at 66330 million in 2021 and is projected to reach US$ 88530 million by 2028, at a CAGR of 4.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tissue Diagnostics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of In-Vitro Diagnostics include Roche, Siemens, Abbott, Danaher, Thermo Fisher, BioMerieux, Bio-Rad, BD and JNJ, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the In-Vitro Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global In-Vitro Diagnostics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global In-Vitro Diagnostics Market Segment Percentages, by Type, 2021 (%)
– Tissue Diagnostics
– Professional Diagnostic
– Molecular Diagnostic
– Diabetes Monitoring
– Other
Global In-Vitro Diagnostics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global In-Vitro Diagnostics Market Segment Percentages, by Application, 2021 (%)
– Diabetes
– Infectious Diseases
– Oncology
– Cardiology
– HIV
– Other
Global In-Vitro Diagnostics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global In-Vitro Diagnostics Market Segment Percentages, By Region and Country, 2021 (%)
– North America
– – US
– – Canada
– – Mexico
– Europe
– – Germany
– – France
– – U.K.
– – Italy
– – Russia
– – Nordic Countries
– – Benelux
– – Rest of Europe
– Asia
– – China
– – Japan
– – South Korea
– – Southeast Asia
– – India
– – Rest of Asia
– South America
– – Brazil
– – Argentina
– – Rest of South America
– Middle East & Africa
– – Turkey
– – Israel
– – Saudi Arabia
– – UAE
– – Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies In-Vitro Diagnostics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies In-Vitro Diagnostics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
– Roche
– Siemens
– Abbott
– Danaher
– Thermo Fisher
– BioMerieux
– Bio-Rad
– BD
– JNJ
– Sysmex
– KHB
– DaAn Gene
– Leadman
– BioSino
– BSBE
– Maccura
More information about Discount offers (25% or More) @ https://www.reportsnreports.com/contacts/discount.aspx?name=5561146
About Us: ReportsnReports.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 95 leading global publishers & in-depth market research studies of over 5000 micro markets.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected]
Phone: +1 888 391 5441